pd168393 has been researched along with Dermatitis, Atopic in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sääf, A | 1 |
Pivarcsi, A | 1 |
Winge, MC | 1 |
Wahlgren, CF | 1 |
Homey, B | 1 |
Nordenskjöld, M | 1 |
Tengvall-Linder, M | 1 |
Bradley, M | 1 |
1 other study available for pd168393 and Dermatitis, Atopic
Article | Year |
---|---|
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients.
Topics: Adolescent; Adult; Cell Differentiation; Cell Line; Chemokine CCL26; Chemokines, CC; Dermatitis, Ato | 2012 |